Faeth Therapeutics, Inc.: Form 8-K, filed Mar 5, 2024
Filed with the SEC on Mar 5, 2024 and accepted by EDGAR at Mar 5, 2024, 16:44 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.03 Change to security holders’ rights
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-24-059356. Last ingested by Listed: Nov 3, 2026, 23:17 ET. Listed shows no prices and gives no investment advice.